SALVATI, ELISA
SALVATI, ELISA
DIPARTIMENTO DI MEDICINA CLINICA E PREVENZIONE (attivo dal 10/07/2006 al 30/09/2012)
FM19G11-Loaded Gold Nanoparticles Enhance the Proliferation and Self-Renewal of Ependymal Stem Progenitor Cells Derived from ALS Mice
2019 Marcuzzo, S; Isaia, D; Bonanno, S; Malacarne, C; Cavalcante, P; Zacheo, A; Laquintana, V; Denora, N; Sanavio, B; Salvati, E; Andreozzi, P; Stellacci, F; Krol, S; Mellado-López, M; Mantegazza, R; Moreno-Manzano, V; Bernasconi, P
Retro-inverso peptide inhibitor nanoparticles as potent inhibitors of aggregation of the Alzheimer's Aβ peptide
2017 Gregori, M; Taylor, M; Salvati, E; Re, F; Mancini, S; Balducci, C; Forloni, G; Zambelli, V; Sesana, M; Michael, M; Michail, C; Tinker Mill, C; Kolosov, O; Scherer, M; Harris, S; Fullwood, N; Masserini, M; Allsop, D
Novel Antitransferrin Receptor Antibodies Improve the Blood-Brain Barrier Crossing Efficacy of Immunoliposomes
2016 Gregori, M; Orlando, A; Re, F; Sesana, M; Nardo, L; Salerno, D; Mantegazza, F; Salvati, E; Zito, A; Malavasi, F; Masserini, M; Cazzaniga, E
Ceramides and sphingomyelinases in senile plaques
2014 Panchal, M; Gaudin, M; Lazar, A; Salvati, E; Rivals, I; Ayciriex, S; Dauphinot, L; Dargère, D; Auzeil, N; Masserini, M; Laprévote, O; Duyckaerts, C
Liposomes bi-functionalized with phosphatidic acid and an ApoE-derived peptide affect Aβ aggregation features and cross the blood-brain-barrier: Implications for therapy of Alzheimer disease
2014 Bana, L; Minniti, S; Salvati, E; Sesana, M; Zambelli, V; Cagnotto, A; Orlando, A; Cazzaniga, E; Zwart, R; Scheper, W; Masserini, M; Re, F
A Novel Retro-Inverso Peptide Inhibitor Reduces Amyloid Deposition, Oxidation and Inflammation and Stimulates Neurogenesis in the APPswe/PS1 Delta E9 Mouse Model of Alzheimer's Disease
2013 Parthsarathy, V; Mcclean, P; Holscher, C; Taylor, M; Tinker, C; Jones, G; Kolosov, O; Salvati, E; Gregori, M; Masserini, M; Allsop, D
Functionalization with TAT-peptide enhances blood-brain barrier crossing in vitro of nanoliposomes carrying a curcumin-derivative to bind amyloid-β peptide
2013 Sancini, G; Gregori, M; Salvati, E; Cambianica, I; Re, F; Ornaghi, F; Canovi, M; Fracasso, C; Cagnotto, A; Colombo, M; Zona, C; Gobbi, M; Salmona, M; LA FERLA, B; Nicotra, F; Masserini, M
Multi-functionalized nanoparticles for therapy and diagnosis of alzheimer's disease
2013 Salvati, E
Solid Lipid Nanoparticles: a strategy to overcome the blood-brain barrier
2013 Dal Magro, R; Ornaghi, F; Cambianica, I; Re, F; Barbero, F; Musicanti, C; Brambilla, A; Salvati, E; Cagnotto, A; Masserini, M; Gasco, P; Sancini, G
Lipid-based nanoparticles as a potential tool to deplete abeta. Toward new therapeutic strategies for Alzheimer’s disease?
2012 DA RE, F; Conti, E; Galimberti, G; Gregori, M; Salvati, E; Tironi, M; Stefanoni, G; Rosa, M; Riva, C; Masserini, M; Ferrarese, C
Functionalization with ApoE-derived peptides enhances the interaction with brain capillary endothelial cells of nanoliposomes binding amyloid-beta peptide
2011 Re, F; Cambianica, I; Sesana, M; Salvati, E; Cagnotto, A; Salmona, M; Couraud, P; Moghimi, S; Masserini, M; Sancini, G
Cap. 6: I fondi duri
2003 Bianchi, C; Pronzato, R; Cattaneo-Vietti, R; Benedetti Cecchi, L; Morri, C; Pansini, M; Chemello, R; Milazzo, M; Fraschetti, S; Terlizzi, A; Peirano, A; Salvati, E; Benzoni, F; Calcinai, B; Cerrano, C; Bavestrello, G
Hard bottoms. In: Mediterranean marine benthos: a manual of methods for its sampling and study
2003 Bianchi, C; Pronzato, R; Cattaneo-Vietti, R; Benedetti Cecchi, L; Morri, C; Pansini, M; Chemello, R; Milazzo, M; Fraschetti, S; Terlizzi, A; Peirano, A; Salvati, E; Benzoni, F; Calcinai, B; Cerrano, C; Bavestrello, G